Loading…
Loading…
The international small-cap equities space may be one of the most overlooked value prospects available to investors right now. In the last two years, the MSXI EAFE Small Cap Index—focused on developed nation small-cap stocks outside of the United States and Canada—has seen some of its lowest valuations relative to domestic large-cap names in decades.
International small-cap value and dividend strategies have quietly become two of the better-performing corners of global equity markets, and the two most popular vehicles to capture them are the Avantis International Small Cap Value ETF (NYSEARCA:AVDV) and the WisdomTree International SmallCap Dividend Fund (NYSEARCA:DLS).
Market participants in the U.S., broadly speaking, already perceive international equities as being more volatile than domestic equivalents. They also believe that scenario is amplified with smaller stocks.
The S&P 500 is easy for investors to access, but it's dominated by large-cap U.S. companies. An ideal complement to these holdings is the WisdomTree International SmallCap Dividend Fund.
Shares of WisdomTree International SmallCap Dividend Fund (NYSEARCA:DLS - Get Free Report) hit a new 52-week high on Thursday. The company traded as high as $81.99 and last traded at $81.67, with a volume of 13789 shares trading hands. The stock had previously closed at $81.56. WisdomTree International SmallCap Dividend Fund Trading Up 0.1%
WisdomTree International SmallCap Dividend Fund (NYSEARCA:DLS - Get Free Report)'s share price hit a new 52-week high during mid-day trading on Friday. The stock traded as high as $81.12 and last traded at $80.6740, with a volume of 4828 shares changing hands. The stock had previously closed at $80.26. WisdomTree International SmallCap Dividend Fund
Investors have long embraced small-caps. That's because of higher growth prospects and diversification within portfolios that often lean into large-caps.
Rehovot, Israel, July 28, 2025 (GLOBE NEWSWIRE) -- Steakholder Foods Ltd. (Nasdaq: STKH), a global leader in 3D-printing technology for structured alt-protein production, announced today that it has received a positive Written Opinion from the International Searching Authority (ISA) regarding its international patent application PCT/US 24/34252.